Published in Heart Disease Weekly, October 17th, 2004
The fourth quarter fiscal year 2004 net sales from continuing operations were level with last year's net sales at approximately $7.8 million. The company reported a net income of $751,000 or $0.32 per share, compared with last year's fourth quarter earnings of $445,000 or $.20 per share.
Net income improved primarily from the elimination of operating expenses associated with the company's disposed Rochester, Minnesota, facility that existed in the prior year.
For fiscal year 2004, net sales from continuing...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Heart Disease Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.